A group of researchers has developed a new technology that sheds light on the HIV infection and will boost the research for drug development. The research shows that the response of latent HIV to reactivation therapies partly depends on the integration site in the human genome.
from Top Health News – ScienceDaily http://ift.tt/2gBgCij
from Tumblr http://ift.tt/2f6Kra8
No comments:
Post a Comment